Curosurf 80 mg/mL

Curosurf 80 mg/mL is a suspension used for respiratory support in premature infants. This poractant alfa formulation aids in lung function and is administered via endotracheal route.

Curosurf 80 mg/mL is primarily used to treat respiratory distress syndrome (RDS) in premature infants. This condition often occurs due to a lack of surfactant in the lungs, which is crucial for proper breathing. The suspension helps to improve lung function and reduce the need for mechanical ventilation. What is Curosurf used for? It is specifically designed to provide respiratory support in neonatal intensive care units.

Common effects of Curosurf 80 mg/mL may include improved lung compliance and reduced respiratory distress. It works by replacing the natural surfactant in the lungs, which helps to keep the air sacs open and functioning properly. This can lead to easier breathing and better oxygenation for the infant.

Curosurf 80 mg/mL should be handled with care and administered by trained medical professionals. It is important to follow proper storage and handling guidelines to maintain the integrity of the suspension. Always consult healthcare providers for specific precautions and contraindications.

Curosurf 80 mg/mL may interact with other medications or treatments. It is important to inform healthcare providers about all current medications and treatments before administration. Specific interactions should be discussed with a healthcare professional to ensure safety and effectiveness.